R. Raj, A. Kumar, Prachi Sood, R. Kumar, and V. Rana, “Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel as First Line Treatment in Women with Advanced Breast Cancer”, J. Res. Appl. Sci. Biotechnol., vol. 2, no. 3, pp. 55–63, Jun. 2023.